↧
Scientific factors for assessing biosimilarity and drug interchangeability of...
Chow SC, Endrenyi L, Lachenbruch PA, Yang LY, Chi E
View ArticleClinical efficacy and safety of HX575, a biosimilar recombinant human...
Abraham I, MacDonald K
View ArticleA European perspective on the market accessibility of biosimilars
Declerck PJ, Simoens S
View ArticleSimilar biotherapeutic products in Latin America. Regulation and...
Desanvicente-Celis Z, Caro-Moreno J, Enciso-Zuluaga M, Anaya JM
View ArticleRituximab and biosimilars – equivalence and reciprocity
Qureshi ZP, Magwood JS, Singh S, Bennett CL
View ArticleCurrent and future biosimilars: potential practical applications in rheumatology
Noaiseh G, Moreland L
View ArticleClinical efficacy and safety of SB309, a biosimilar recombinant human...
Bagalagel A, Mohammed A, MacDonald K, Abraham I
View ArticleClinical efficacy and safety of Tevagrastim® (XM02), a biosimilar...
Bagalagel A, Mohammed A, MacDonald K, Abraham I
View ArticleClinical efficacy and safety of XM01, a biosimilar recombinant human...
Mohammed A, Bagalagel A, MacDonald K, Abraham I
View ArticleClinical efficacy and safety of Zarzio® (EP2006), a biosimilar...
Tharmarajah S, Mohammed A, Bagalagel A, MacDonald K, Abraham I
View ArticleProduction and analysis of a biosimilar erythropoietin in Egypt
Ebied WM, Ahmed HM, Elbarbry FA
View ArticleAssessing biosimilarity of follow on biologics
Chow SC, Endrenyi L, Lachenbruch PA, Yang LY, Chi E
View Article